Table 6 HIV antibody prevalence and undiagnosed infection in community samples of MSM in selected countries
| Location | Year conducted | Recruitment sites | Sample size* | HIV prevalence (%) | Proportion undiagnosed (%) | Ref |
|---|---|---|---|---|---|---|
| England (3 cities) | 2003-4 | GB, GS | 348 | 8.6% Manchester | 36.7% Manchester | [13, 14] |
| 1436 | 12.3% London | 44.1% London | ||||
| 373 | 13.7% Brighton | 33.3% Brighton | ||||
| Scotland (2 cities) | 2005 | GB, GS | 749 | 3.6% Glasgow | 48.1% Glasgow | [14, 15] |
| 601 | 5.5% Edinburgh | 36.4% Edinburgh | ||||
| Southern Africa (3 countries) | 2008 | SB | 537 | 17.4% | 76.3% | [16] |
| United States (21 cities) | 2008 | GB, SO | 8153 | 19.2% overall | 43.5% overall | [17] |
| 6.4% Atlanta (low) | 15.4% Seattle (low) | |||||
| 37.8% Baltimore (high) | 73.4% Baltimore (high) | |||||
| Australia (2 cities) | 2008 | GB, GS | 465 | 8.8% Brisbane | 19.5% Brisbane | [18] |
| 639 | 9.5% Melbourne | 31.1% Melbourne | [12] | |||
| France (Paris) | 2009 | GB, GS | 886 | 17.7% | 20% | |
| New Zealand (Auckland) | 2011 |
GB, GS, CE | 1049 | 6.5% | 20.9% | [19] |
